Area of research
Oncology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Acute Lymphoblastic Leukemia research, CAR-T cell therapy research, and Acute Myeloid Leukemia Research.
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80+).
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center